The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...

Tabak, a dentist and researcher, was appointed as the NIH’s principal deputy director in 2010. His tenure spans four presidential administrations, and includes a nearly two-year stint as the ...

National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...

His research has been funded by the NIH. Working in an historical archive is a lot like laboratory science. Lots of noise and too little signal. You can spend a day plowing through routine ...

Scientific researchers are concerned after the National Institutes of Health (NIH) abruptly canceled numerous meetings essential to the fellowship and grant approval process earlier this week.

Within hours, as word of NIH meeting cancellations pinged across the social media platform Bluesky, she realized that this wasn’t only about the opioid research she would be reviewing ...

The NIH, the largest funder of biomedical research in the U.S., will limit funding for indirect costs to 15%. Indirect costs cover expenses like building maintenance and administrative salaries.

“Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.” The NIH is the primary source of federal funding for medical ...

Though Memoli is an NIH insider, one source familiar with him noted his perspectives —particularly his opposition to Covid-19 vaccine mandates — make him more of an outsider at the agency.

Research leaders contend that the NIH decision will damage America’s ability to compete with China and other nations on the frontier of biomedicine. Although it is framed as a simple cost ...